BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

346 related articles for article (PubMed ID: 36497169)

  • 1. Hematopoietic Cell Transplantation for Systemic Sclerosis-A Review.
    Levin D; Osman MS; Durand C; Kim H; Hemmati I; Jamani K; Howlett JG; Johannson KA; Weatherald J; Woo M; Lee J; Storek J
    Cells; 2022 Dec; 11(23):. PubMed ID: 36497169
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stem Cell Therapy as a Treatment for Autoimmune Disease-Updates in Lupus, Scleroderma, and Multiple Sclerosis.
    Ramalingam S; Shah A
    Curr Allergy Asthma Rep; 2021 Mar; 21(3):22. PubMed ID: 33759038
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autologous stem cell transplantation in scleroderma.
    Farge D; Ait Abdallah N; Marjanovic Z; Del Papa N
    Presse Med; 2021 Apr; 50(1):104065. PubMed ID: 33548374
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunosuppressive Therapy After Autologous Hematopoietic Stem Cell Transplantation in Systemic Sclerosis Patients-High Efficacy of Rituximab.
    Gernert M; Tony HP; Fröhlich M; Schwaneck EC; Schmalzing M
    Front Immunol; 2021; 12():817893. PubMed ID: 35111167
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Case report: A successful second autologous hematopoietic stem cell transplantation in refractory systemic sclerosis, with positive effect on skin involvement, pulmonary function and microcirculation.
    Haverkort DA; Kersten BE; van Rhenen A; van der Velden WJFM; Vonk MC
    Front Immunol; 2022; 13():925776. PubMed ID: 36505455
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase I/II trial of autologous stem cell transplantation in systemic sclerosis: procedure related mortality and impact on skin disease.
    Binks M; Passweg JR; Furst D; McSweeney P; Sullivan K; Besenthal C; Finke J; Peter HH; van Laar J; Breedveld FC; Fibbe WE; Farge D; Gluckman E; Locatelli F; Martini A; van den Hoogen F; van de Putte L; Schattenberg AV; Arnold R; Bacon PA; Emery P; Espigado I; Hertenstein B; Hiepe F; Kashyap A; Kötter I; Marmont A; Martinez A; Pascual MJ; Gratwohl A; Prentice HG; Black C; Tyndall A
    Ann Rheum Dis; 2001 Jun; 60(6):577-84. PubMed ID: 11350846
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autologous Hematopoietic Stem Cell Transplantation for Treatment of Systemic Sclerosis.
    Del Papa N; Pignataro F; Zaccara E; Maglione W; Minniti A
    Front Immunol; 2018; 9():2390. PubMed ID: 30386340
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autologous stem cell transplantation for progressive systemic sclerosis: a prospective non-interventional study from the European Society for Blood and Marrow Transplantation Autoimmune Disease Working Party.
    Henes J; Oliveira MC; Labopin M; Badoglio M; Scherer HU; Del Papa N; Daikeler T; Schmalzing M; Schroers R; Martin T; Pugnet G; Simoes B; Michonneau D; Marijt EWA; Lioure B; Olivier Bay J; Snowden JA; Rovira M; Huynh A; Onida F; Kanz L; Marjanovic Z; Farge D
    Haematologica; 2021 Feb; 106(2):375-383. PubMed ID: 31949011
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autologous Haematopoietic Stem Cell Transplantation and Systemic Sclerosis: Focus on Interstitial Lung Disease.
    Bagnato G; Versace AG; La Rosa D; De Gaetano A; Imbalzano E; Chiappalone M; Ioppolo C; Roberts WN; Bitto A; Irrera N; Allegra A; Pioggia G; Gangemi S
    Cells; 2022 Mar; 11(5):. PubMed ID: 35269465
    [TBL] [Abstract][Full Text] [Related]  

  • 10. French protocol for the diagnosis and management of hematopoietic stem cell transplantation in autoimmune diseases.
    Farge D; Pugnet G; Allez M; Castilla-Llorente C; Chatelus E; Cintas P; Faucher-Barbey C; Labauge P; Labeyrie C; Lioure B; Maria A; Michonneau D; Puyade M; Talouarn M; Terriou L; Treton X; Wojtasik G; Zephir H; Marjanovic Z;
    Rev Med Interne; 2024 Feb; 45(2):79-99. PubMed ID: 38220493
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mesenchymal Stem Cell-Based Therapy as a New Approach for the Treatment of Systemic Sclerosis.
    Zhuang X; Hu X; Zhang S; Li X; Yuan X; Wu Y
    Clin Rev Allergy Immunol; 2023 Jun; 64(3):284-320. PubMed ID: 35031958
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autologous stem-cell transplantation in refractory autoimmune diseases after in vivo immunoablation and ex vivo depletion of mononuclear cells.
    Rosen O; Thiel A; Massenkeil G; Hiepe F; Häupl T; Radtke H; Burmester GR; Gromnica-Ihle E; Radbruch A; Arnold R
    Arthritis Res; 2000; 2(4):327-36. PubMed ID: 11056673
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of systemic sclerosis: the first five years.
    Roofeh D; Khanna D
    Curr Opin Rheumatol; 2020 May; 32(3):228-237. PubMed ID: 32205570
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Autologous stem cell transplantation in systemic sclerosis].
    Henes JC; Wirths S; Kötter I
    Z Rheumatol; 2016 Oct; 75(8):762-769. PubMed ID: 27510996
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Positron Emission Tomography to Improve Assessment of Interstitial Lung Disease in Patients With Systemic Sclerosis Eligible for Autologous Stem Cell Transplantation.
    Broens B; van der Laken CJ; Zwezerijnen GJC; Nossent EJ; Meijboom LJ; Spierings J; de Vries-Bouwstra JK; van Laar JM; Voskuyl AE
    Front Immunol; 2022; 13():923869. PubMed ID: 35865521
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hematopoietic stem cell transplantation for systemic sclerosis: history and current status.
    Burt RK; Milanetti F
    Curr Opin Rheumatol; 2011 Nov; 23(6):519-29. PubMed ID: 21857226
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current and future perspectives on management of systemic sclerosis-associated interstitial lung disease.
    Distler O; Volkmann ER; Hoffmann-Vold AM; Maher TM
    Expert Rev Clin Immunol; 2019 Oct; 15(10):1009-1017. PubMed ID: 31566449
    [No Abstract]   [Full Text] [Related]  

  • 18. Stem cell therapies for systemic sclerosis.
    Cipriani P; Ruscitti P; Giacomelli R
    Br J Haematol; 2015 Feb; 168(3):328-37. PubMed ID: 25376920
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute kidney injury in patients with systemic sclerosis participating in hematopoietic cell transplantation trials in the United States.
    Hosing C; Nash R; McSweeney P; Mineishi S; Seibold J; Griffith LM; Shulman H; Goldmuntz E; Mayes M; Parikh CR; Crofford L; Keyes-Elstein L; Furst D; Steen V; Sullivan KM
    Biol Blood Marrow Transplant; 2011 May; 17(5):674-81. PubMed ID: 20708086
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment of systemic sclerosis-associated interstitial lung disease].
    Prasse A; Bonella F; Müller-Ladner U; Witte T; Hunzelmann N; Distler J
    Z Rheumatol; 2020 Apr; 79(3):294-303. PubMed ID: 31754786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.